CONFIRM anti-Ki-67 (30-9) Rabbit Monoclonal Primary Antibody

CONFIRM anti-Ki-67 (30-9) Rabbit Monoclonal Primary Antibody, tonsil, 100x

This antibody is intended for in vitro diagnostic (IVD) use.

Ventana Medical Systems' (Ventana) CONFIRM anti-Ki-67 (30-9) Primary Antibody is a rabbit monoclonal antibody (IgG) directed against C-terminal portion of Ki-67 antigen. Staining for Ki-67 can be used to aid in assessing the proliferative activity of normal and neoplastic tissue.1,2,3 This antibody is intended for use to identify stained proliferating cells by light microscopy in sections of formalin-fixed, paraffin-embedded tissue on a Ventana automated slide stainer.

The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.

  1.  Keng PC, Siemann DW. Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods. Radiatn Oncol Investig, 6(3): 120-7, 1998
  2.  Rey A Lara PC. Ki67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival. Arch Esp Urol, 51(2): 204-10, 1998.
  3.  Bacchi CE, Gown AM. Detection of cell proliferation in tissue sections. Braz J Med Biol Res, 26(7): 677-87, 1993.
  4.  Alliegro M. Coiled body heterogeneity induced by G(1) arrest with amiloride bumetanide. Exp Cell Res, 279(1): 111-17, 2002.
  5.  Scholzen T Gerdes J. The Ki-67 protein from the know and the unknown. J Cell Physiol, 182(3): 311-22, 2000.
  6.  Sheehan DC, Hrapchak BB. Theory and practice of histotechnology, 2nd Edition. The C.V. Mosby Company, St. Louis, 1980. 2008-11-12 Page 5 of 6 20687EN Rev D
  7.  College of American Pathologists Laboratory Accreditation Program, Anatomic Pathology Checklist, 2001.
  8.  NCCLS. Quality Assurance for Immunocytochemistry: Approved Guideline. NCCLS document MM4-A- (ISBN 1-56238-396-5).
  9. NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898 USA, 1999.
  10.  Herman GE, Elfont EA. The taming of immunohistochemistry: the new era of quality control. Biotech Histochem 66(4): 194-199, 1991.
  11.  Omata M, Liew CT, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen. A possible source of error in immunohistochemistry. Am J Clin Pathol 73(5): 626-32, 1980.
  12.  Nadji M, Morales AR. Immunoperoxidase: part 1. The technique and its pitfalls. Lab Med 14: 767, 1983.
  13.  Roche PC, Hsi ED. Immunohistochemistry-Principles and Advances. Manual of Clinical Laboratory Immunology, 6th edition. (NR Rose Ed.) ASM Press, 2002.